Beijing Tiantan Biological Products Corp Ltd Free Cash Flow Generation Index
Beijing Tiantan Biological Products Corp Ltd free cash flow generation index. Beijing Tiantan Biological Products Corp Ltd (600161) has a Free Cash Flow Generation Index of 0.61x as of September 2025. Free cash flow of CN¥193.73 Million represents 1% of operating cash flow (CN¥318.80 Million). Check 600161 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Free cash flow generation index of Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. Historical FCF Generation Index trend for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Explore how much does Beijing Tiantan Biological Products Corp reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Beijing Tiantan Biological Products Corp Ltd Free Cash Flow Generation Index by Year (1998–2024)
Beijing Tiantan Biological Products Corp Ltd free cash flow generation index by year from 1998 to 2024. Year-by-year Free Cash Flow Generation Index for Beijing Tiantan Biological Products Corp Ltd. For the full cash flow conversion analysis, see cash flow conversion of Beijing Tiantan Biological Products Corp.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.30x | CN¥-247.63 Million | CN¥819.78 Million | CN¥1.07 Billion | ▼ -154.9% |
| 2023 | 0.55x | CN¥1.32 Billion | CN¥2.39 Billion | CN¥1.08 Billion | ▲ +371.5% |
| 2022 | -0.20x | CN¥-228.02 Million | CN¥1.13 Billion | CN¥1.35 Billion | ▼ -31.2% |
| 2021 | -0.15x | CN¥-151.35 Million | CN¥980.35 Million | CN¥1.13 Billion | ▼ -216.3% |
| 2020 | 0.13x | CN¥93.20 Million | CN¥702.11 Million | CN¥608.91 Million | ▼ -26.6% |
| 2019 | 0.18x | CN¥116.24 Million | CN¥642.47 Million | CN¥526.23 Million | ▼ -68.1% |
| 2018 | 0.57x | CN¥384.01 Million | CN¥677.92 Million | CN¥293.90 Million | ▲ +68.3% |
| 2017 | 0.34x | CN¥73.52 Million | CN¥218.39 Million | CN¥144.87 Million | ▼ -34.1% |
| 2016 | 0.51x | CN¥218.98 Million | CN¥428.37 Million | CN¥209.39 Million | ▲ +40.1% |
| 2015 | 0.36x | CN¥172.68 Million | CN¥473.26 Million | CN¥300.57 Million | ▲ +1164.1% |
| 2014 | 0.03x | CN¥13.80 Million | CN¥477.95 Million | CN¥464.16 Million | ▼ -9.5% |
| 2013 | 0.03x | CN¥18.06 Million | CN¥566.43 Million | CN¥548.37 Million | ▲ +110.9% |
| 2012 | -0.29x | CN¥-125.87 Million | CN¥432.00 Million | CN¥557.87 Million | ▲ +71.9% |
| 2011 | -1.04x | CN¥-365.52 Million | CN¥353.15 Million | CN¥718.67 Million | ▼ -69.8% |
| 2010 | -0.61x | CN¥-112.68 Million | CN¥184.85 Million | CN¥297.54 Million | ▼ -206.3% |
| 2009 | 0.57x | CN¥257.06 Million | CN¥448.23 Million | CN¥191.17 Million | ▲ +25.7% |
| 2008 | 0.46x | CN¥126.08 Million | CN¥276.39 Million | CN¥150.31 Million | ▼ -19.6% |
| 2007 | 0.57x | CN¥87.14 Million | CN¥153.55 Million | CN¥66.40 Million | ▲ +5.7% |
| 2006 | 0.54x | CN¥82.86 Million | CN¥154.36 Million | CN¥71.50 Million | ▼ -23.1% |
| 2005 | 0.70x | CN¥91.90 Million | CN¥131.69 Million | CN¥39.78 Million | ▲ +217.4% |
| 2004 | 0.22x | CN¥24.21 Million | CN¥110.11 Million | CN¥85.89 Million | ▲ +151.1% |
| 2003 | -0.43x | CN¥-27.09 Million | CN¥62.93 Million | CN¥90.02 Million | ▼ -173.3% |
| 2002 | 0.59x | CN¥49.56 Million | CN¥84.38 Million | CN¥34.83 Million | ▲ +1151.0% |
| 2001 | -0.06x | CN¥-2.60 Million | CN¥46.49 Million | CN¥49.09 Million | ▼ -169.3% |
| 2000 | 0.08x | CN¥3.86 Million | CN¥47.90 Million | CN¥44.04 Million | ▲ +551.9% |
| 1999 | -0.02x | CN¥-759.96K | CN¥42.58 Million | CN¥43.34 Million | ▲ +98.8% |
| 1998 | -1.43x | CN¥-33.90 Million | CN¥23.71 Million | CN¥57.61 Million | — |